A Mass Balance Study With a Microtracer Dose of 14C-esketamine in Healthy Male Participants
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the metabolic disposition of radiolabeled
esketamine administered by the oral and intravenous routes in healthy male participants.